Ozempic weight loss claims on TikTok: what the data says

What did @tammyk056 actually say?

The video caption does most of the talking here. @tammyk056 reports losing 12kg since starting semaglutide (Ozempic) on 6 August 2025, dropping from 103kg to 91kg. She describes a titration schedule starting at 0.25mg for four weeks, then 0.5mg for four weeks (she wrote 0.05mg, which appears to be a typo), and currently 1mg. Her dietary changes are described as modest: smaller portions using a side plate and intermittent fasting from 8pm onward. She explicitly states there were "no major changes" in her eating beyond these two adjustments. The actual spoken transcript is unrelated to weight loss, so this fact-check focuses entirely on the caption claims.

Worth noting: the dose she listed as "0.05mg" is almost certainly 0.5mg. That is the standard second step in the Ozempic titration protocol. Assuming that correction, her reported titration matches the prescribing guidelines exactly.

Does the science back this up?

Yes, mostly. A 12kg loss over roughly the timeframe described is plausible and consistent with published trial data, though it sits at the higher end of early-phase results. The SUSTAIN 1 trial (Aroda et al., 2017, Diabetes Care) showed meaningful weight reductions with semaglutide even at lower doses, and the STEP 1 trial (Wilding et al., 2021, NEJM) demonstrated average losses of around 14.9% body weight over 68 weeks at 2.4mg. At 103kg starting weight, a 12kg loss represents about 11.6% body weight, which is within realistic range for the early months on the drug.

The combination of smaller portions and time-restricted eating alongside semaglutide also has some support. Semaglutide slows gastric emptying and reduces appetite via GLP-1 receptor activation in the hypothalamus, which makes portion reduction feel less effortful. A 2022 study by Rubino et al. in NEJM showed that behavioral changes compound the drug's effects. Her approach is not reckless or implausible.

What did they get wrong (or right)?

The titration schedule, assuming the 0.05mg is a typo for 0.5mg, is actually correct. Standard Ozempic titration starts at 0.25mg for four weeks, steps up to 0.5mg, then to 1mg. She followed this precisely. Credit where it is due: a lot of creators on TikTok describe chaotic, self-directed dose escalations. She did not do that.

What is harder to verify is the claim of "no major changes" in eating. Semaglutide reliably suppresses appetite, so her portion reduction and evening fasting window may feel effortless to her but still represent a meaningful caloric reduction. Describing this as minimal change could mislead viewers into thinking the drug alone is doing all the work. Research by Davies et al. (2021, Lancet) consistently shows that GLP-1 agonists work best alongside dietary behavior changes, even ones that feel small. The drug likely made those changes easier, not irrelevant.

• Dose titration: appears accurate (assuming typo correction)
• Weight loss magnitude: plausible and consistent with early-phase data
• "No major changes" framing: technically true but potentially misleading about how the drug works

What should you actually know?

A few things matter here for anyone watching this video and considering starting semaglutide. First, individual results vary enormously. The STEP trials show wide distributions around their averages. Some people lose 5%, some lose 20%. A 12kg result in the early months is good, but it is not a guarantee for anyone else.

Second, Ozempic is licensed in most countries for type 2 diabetes management, not weight loss. Wegovy, the higher-dose formulation of semaglutide at 2.4mg, carries the weight-loss indication. Using Ozempic off-label for obesity is common and clinically practiced, but patients should understand what they are taking and why, ideally with a prescribing clinician involved.

Third, stopping the drug tends to reverse the losses. A 2022 withdrawal study by Wilding et al. in Diabetes, Obesity and Metabolism found that participants regained about two-thirds of lost weight within a year of stopping semaglutide. The video does not mention this, and most TikTok weight loss content does not. It is an important omission.

Finally, the 20:00 intermittent fasting window she describes is a time-restricted eating approach. It is mild, probably beneficial, and unlikely to cause harm alongside semaglutide for most people. But anyone with a history of disordered eating should discuss fasting approaches with a clinician before combining them with appetite-suppressing medication.